carbapenems has been researched along with l 749345 in 19 studies
Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (l 749345) | Trials (l 749345) | Recent Studies (post-2010) (l 749345) |
---|---|---|---|---|---|
7,355 | 147 | 5,277 | 19 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (42.11) | 18.2507 |
2000's | 11 (57.89) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gill, CJ; Hajdu, R; Kropp, H; Rosen, H; Sundelof, JG; Thompson, R | 1 |
Han, P; Jacoby, G; Tran, J | 1 |
Gerckens, LS; Gill, CJ; Jackson, JJ; Kropp, H; Pelak, BA; Rosen, H; Sundelof, JG; Thompson, RK | 1 |
Cars, O; Löwdin, E; Odenholt, I | 1 |
Birk, KL; Cairns, AM; Majumdar, AK; Musson, DG; Rogers, JD | 1 |
Bruhin, PJ; Lin, JH; Wong, BK | 1 |
Dorso, KL; Hammond, GG; Kohler, J; Kropp, H; Rosen, H; Silver, LL; Young, K | 1 |
Barry, AL; Brown, SD; Fuchs, PC | 2 |
Finegold, SM; Molitoris, D; Wexler, HM | 1 |
Citron, DM; Goldstein, EJ; Tyrrell, KL; Vreni Merriam, C; Warren, Y | 1 |
Bagel, S; Baquero, F; Bell, J; Carter, MW; Endtz, HP; Fernandes, CJ; Fernandes, L; Frimodt-Moller, N; Giamarellos-Bourboulis, E; Giamarellou, H; Jarlier, V; Livermore, DM; Loza, E; Mixson, L; Nguyen, J; Nonhoff, C; Nord, CE; Pfister, S; Rasmussen, LS; Shungu, DL; Struelens, MJ; Turnidge, J; van Den Braak, N; Wiedemann, B; Zbinden, R | 1 |
Betriu, C; Gómez, M; Palau, ML; Picazo, JJ; Sánchez, A | 1 |
Carter, MW; Livermore, DM; Oakton, KJ; Warner, M | 1 |
Jones, RN | 1 |
Citron, DM; Fernandez, H; Goldstein, EJ; Merriam, CV; Tyrrell, K; Warren, YA | 1 |
Appelbaum, PC; Davies, TA; Jacobs, MR; Pankuch, GA | 1 |
Anthony, L; Appelbaum, PC; Credito, K; Ednie, LM; Hoellman, DB; Jacobs, MR; Kelly, LM | 1 |
Hochman, JH; Lin, JH; Ohe, T; Yamazaki, M | 1 |
1 review(s) available for carbapenems and l 749345
Article | Year |
---|---|
Evaluation of drug interactions with P-glycoprotein in drug discovery: in vitro assessment of the potential for drug-drug interactions with P-glycoprotein.
Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Assay; Biological Transport; Carbapenems; Cells, Cultured; Drug Design; Drug Interactions; In Vitro Techniques; Pharmaceutical Preparations; Species Specificity; Structure-Activity Relationship; Tissue Distribution | 2002 |
18 other study(ies) available for carbapenems and l 749345
Article | Year |
---|---|
Pharmacokinetics of L-749,345, a long-acting carbapenem antibiotic, in primates.
Topics: Animals; Carbapenems; Half-Life; Humans; Macaca mulatta; Male; Pan troglodytes; Protein Binding; Species Specificity | 1997 |
Comparative in vitro activities of carbapenem L-749,345 and other antimicrobials against multiresistant gram-negative clinical pathogens.
Topics: beta-Lactam Resistance; Carbapenems; Drug Resistance, Multiple; Gram-Negative Bacteria; Microbial Sensitivity Tests | 1997 |
In vivo activity and pharmacokinetic evaluation of a novel long-acting carbapenem antibiotic, MK-826 (L-749,345).
Topics: Animals; Bacterial Infections; Carbapenems; Female; Mice; Mice, Inbred DBA; Rats; Rats, Sprague-Dawley | 1998 |
In vitro pharmacodynamic studies of L-749,345 in comparison with imipenem and ceftriaxone against gram-positive and gram-negative bacteria.
Topics: Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests | 1998 |
High-performance liquid chromatographic methods for the determination of a new carbapenem antibiotic, L-749,345, in human plasma and urine.
Topics: Anti-Infective Agents; Calibration; Carbapenems; Chromatography, High Pressure Liquid; Humans; Reference Standards; Reproducibility of Results; Spectrophotometry, Ultraviolet | 1998 |
Dose-dependent plasma clearance of MK-826, a carbapenem antibiotic, arising from concentration-dependent plasma protein binding in rats and monkeys.
Topics: Animals; Blood Proteins; Carbapenems; Chromatography, Liquid; Dose-Response Relationship, Drug; Injections, Intravenous; Macaca mulatta; Male; Protein Binding; Rats; Rats, Sprague-Dawley; Spectrophotometry, Ultraviolet | 1999 |
In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum beta-lactamase-and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolates.
Topics: beta-Lactamases; Carbapenems; Cephalosporin Resistance; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests | 1999 |
In-vitro antimicrobial activity of a carbapenem, MK-0826 (L-749,345) and provisional interpretive criteria for disc tests.
Topics: Bacteria, Aerobic; Bacteria, Anaerobic; Carbapenems; Enterobacteriaceae; Imipenem; Microbial Sensitivity Tests | 1999 |
In vitro activities of MK-826 (L-749,345) against 363 strains of anaerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Carbapenems; Clostridium perfringens; Fusobacterium nucleatum; Humans; Microbial Sensitivity Tests; Peptostreptococcus | 2000 |
Comparative In vitro activities of ertapenem (MK-0826) against 1,001 anaerobes isolated from human intra-abdominal infections.
Topics: Abdominal Abscess; Bacteria, Anaerobic; Brazil; Carbapenems; Humans; Microbial Sensitivity Tests; Russia; South Africa; Spain | 2000 |
In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia.
Topics: Anti-Bacterial Agents; Australia; Bacteria; Carbapenems; Europe; Microbial Sensitivity Tests; Quality Control | 2001 |
In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers.
Topics: Anti-Bacterial Agents; Carbapenems; Enterobacteriaceae; Gram-Positive Bacteria; Microbial Sensitivity Tests; North America | 2001 |
In vitro activities of MK-0826 and 16 other antimicrobials against Bacteroides fragilis group strains.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; Carbapenems; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests | 2001 |
Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Enterobacteriaceae; Humans; Klebsiella; Microbial Sensitivity Tests; Mutation | 2001 |
In vitro evaluation of ertapenem (MK-0826), a long-acting carbapenem, tested against selected resistant strains.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Ciprofloxacin; Drug Evaluation; Drug Resistance; Drug Synergism; Gentamicins; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Phenotype | 2001 |
Comparative in vitro activity of ertapenem and 11 other antimicrobial agents against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bites, Human; Carbapenems; Humans; Microbial Sensitivity Tests; Skin Diseases, Bacterial; Soft Tissue Infections; Wound Infection | 2001 |
Antipneumococcal activity of ertapenem (MK-0826) compared to those of other agents.
Topics: Amoxicillin; Carbapenems; Humans; Microbial Sensitivity Tests; Penicillins; Streptococcus pneumoniae; Time Factors | 2002 |
In vitro antianaerobic activity of ertapenem (MK-0826) compared to seven other compounds.
Topics: Bacteria, Anaerobic; Carbapenems; Ceftriaxone; Cephalosporins; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2002 |